Active · per the CBE, 16 November 2026

ESPharma

BE1014613268

Rechtspersoon Private limited company 2 establishments

ESPharma is a pharmacy in Anderlecht. Private Limited, started on 3 October 2024, 2 establishments.

Henri Caronstraat 7/0001, 1070 Anderlecht [email protected]

Behind the company: Emilie Sabine Spilborghs.

Active for

2 year, 1 month

Financials

Financial year 2025

ESPharma from Anderlecht, company number BE1014613268, closed financial year 2025 with a result of € 40,204 after tax. For that financial year ESPharma recorded a gross margin of € 51,161 and equity of € 55,529. Compared with financial year 2024, the result moved from € 15,491 to € 40,204. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 55,529

▲ 244% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 40,204

▲ 160% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 26,514

▲ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 833 paid out

2 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,122

▲ € 962 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,333

▲ 86% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
20242025Change 2024 → 2025
Gross margin € 20,543 € 51,161 ▲ 149%
Profit after taxes € 15,491 € 40,204 ▲ 160%
Equity € 16,158 € 55,529 ▲ 244%
Total debts € 11,155 € 19,296 ▲ 73%
Cash € 25,044 € 26,514 ▲ 6%
Retained profit € 14,658 € 54,029 ▲ 269%
Dividend € 833 € 833
Balance sheet total € 27,314 € 74,825 ▲ 174%

By gross margin, ESPharma ranks 40th of 52 companies with main activity “Detailhandel in farmaceutische producten” in Anderlecht that publish figures (fiscal year 2025).

Key figures of ESPharma, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ESPharma?

What happened at ESPharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New establishment in La Roche-en-Ardenne. KBO
  • New annual accounts for financial year 2025: profit of € 40,204 (▲ 160% vs 2024). Source: NBB ↗
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Anderlecht. KBO
  • Emilie Sabine Spilborghs became a director. NBB

In short

From € 15,491 profit in 2024 to € 40,204 profit in 2025.

Paid € 15,192 in corporate taxes since 2024.

Best year ever: 2025, with € 40,204 profit.

Paid out € 1,666 in dividends to the owners in total.

Management

Emilie Sabine Spilborghs
ESPharma

Behind ESPharma is Emilie Sabine Spilborghs.

Directors

According to the 2025 annual accounts

Emilie Sabine Spilborghs

Director

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Henri Caronstraat 7/0001

1070 Anderlecht

2.396.373.518

Rue de Cielle 4 box A 2 LA0003

6980 La Roche-en-Ardenne

Active since 1 October 2026

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Anderlecht

Same main activity (Detailhandel in farmaceutische producten), 57 active companies in Anderlecht, largest first.

Multipharma

€ 580.8 million revenue · 2025

Popelin Apotheken

€ 152.2 million revenue · 2025

Les Pharmaciens Associés

€ 16.9 million revenue · 2025

Horus Pharma Belux

€ 1.9 million gross margin · 2024

"WESTLAND PHARMA"

€ 914,402 gross margin · 2025

PHARMACIE LAURENT DELCOURT

€ 870,107 gross margin · 2026

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • SPILBORGHS Emilie Sabine Philippine(oprichter) 100%

Details

Company number
1014.613.268
VAT number
BE 1014.613.268
Registered office
Henri Caronstraat 7/0001, 1070 Anderlecht
Names & denominations
ESPharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
3 October 2024
Peppol
Active · Active since 15 Dec 2025
Activities · NACE

Detailhandel in farmaceutische producten

Frequently asked questions

What does ESPharma do?
ESPharma is a pharmacy in Anderlecht. Private Limited, started on 3 October 2024, 2 establishments.
What is the address of ESPharma?
The registered office of ESPharma is located at Henri Caronstraat 7/0001, 1070 Anderlecht.
Is ESPharma still active?
Yes. According to the CBE (16 November 2026) ESPharma is active, legal situation “Normale toestand”, started on 3 October 2024.
Is ESPharma registered on Peppol?
Yes, ESPharma is registered on the Peppol network with ID 0208:1014613268.
What is the enterprise number of ESPharma?
The enterprise number of ESPharma is BE1014613268.
When was ESPharma founded?
ESPharma was founded on 3 October 2024.